Results 51 to 60 of about 166,414,594 (349)

Cost of healthcare services in patients with chronic rhinosinusitis from the public hospital perspective: a retrospective prevalence-based costing approach [PDF]

Journal of Pharmacy & Pharmacognosy Research, 2019
Context: Chronic rhinosinusitis (CRS) is a high-incidence health concern and therefore cause a high economic burden. Aim: To evaluate the direct medical cost in CRS treatment.
Trung Quang Vo
doaj  

A COST VARIATION ANALYSIS OF DRUGS PRE-SCRIBED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

National Journal of Medical Research, 2023
Background: The rheumatologists have several drugs to choose from, either alone or in combination; each with different costs, monitoring protocols, and potential risks and benefits. Pharmacoeconomic analysis results help rheumatologists choose drugs for
Yash Panchal, Bhavesh Vyas
doaj   +1 more source

Tuberculosis: cost of illness in Germany [PDF]

European Respiratory Journal, 2012
4,444 new cases of tuberculosis (TB) were reported in Germany in 2009; of those, the proportion of multidrug-resistant (MDR)-TB cases increased to 2.1% (63 cases).On the basis of the therapy guidelines of the German Central Committee against Tuberculosis and the new World Health Organization guidelines, this study estimates the mean direct outpatient ...
Roland, Diel, Stefan, Rutz, Stefanie, Castell, Tom, Schaberg   +3 more
openaire   +2 more sources

Mapping the Cost of Illness Publications in Five Decades: A Bibliometric Analysis and Publications Landscape

Uluslararası Ekonomi, İşletme ve Politika Dergisi
The study aims to map the "cost-of-illness" publications over five decades, identify research areas and conduct a bibliometric analysis of publications on the cost of illness. Study data was obtained from Web of Science database in April 2024.
Nazife Öztürk
doaj   +1 more source

Cost-of-illness studies of inherited retinal diseases: a systematic review

Orphanet Journal of Rare Diseases
Background While health care and societal costs are routinely modelled for most diseases, there is a paucity of comprehensive data and cost-of-illness (COI) studies for inherited retinal diseases (IRDs).
Q. Ng, Clarence Ong, C. Yaow, H. W. Chan, J. Thumboo, Yi Wang, Gerald Choon Huat Koh   +6 more
semanticscholar   +1 more source

Economic burden of COVID-19, China, January–March, 2020: a cost-of-illness study

Bulletin of the World Health Organization, 2020
Objective To estimate the economic cost of coronavirus disease 19 (COVID-19) in 31 provincial-level administrative regions and in total, in China. Methods We used data from government reports, clinical guidelines and other publications to estimate the ...
Huajie Jin, Hai-Yin Wang, Xiao Li, Weiwei Zheng, Shanke Ye, Sheng Zhang, Jiahui Zhou, M. Pennington   +7 more
semanticscholar   +1 more source

Costs of inadvertent perioperative hypothermia in Australia: a cost-of-illness study

, 2020
Background: A definitive cost analysis of preventing inadvertent perioperative hypothermia (IPH) in surgical patients in Australia is lacking. Preventing IPH is a common nurse-led initiative in surgery and cost savings represent the value of nursing care.
Gow, Jeff, Bräuer, Anselm, Ralph, Nicholas, Conway, Aaron, Gow, Jeffrey, Duff, Jed, Edward, Karen-leigh, Alexander, Kimberley, Alexander, Kim   +8 more
core   +1 more source

A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.

Multiple Sclerosis and Related Disorders, 2020
BACKGROUND Multiple sclerosis has both high healthcare and social impacts. OBJECTIVE The purpose of this article is to analyse the available literature describing the economic burden of multiple sclerosis and to compare costs among studies examining ...
M. Paz-Zulueta, P. Parás-Bravo, D. Cantarero-Prieto, C. Blázquez-Fernández, A. Oterino-Durán   +4 more
semanticscholar   +1 more source

Cost of illness of RSV infection in a middle-income tropical country.

Turkish Journal of Pediatrics, 2021
BACKGROUND Despite the burden of disease of Respiratory syncytial virus (RSV) infection in children, there are important gaps in knowledge about the potential impact in terms of health as well as social and healthcare resources. The aim of this study was
J. Buendía, D. G. Patiño, D. Sinisterra   +2 more
semanticscholar   +1 more source

Safety and Effectiveness of a High‐Dose, Tailored Tissue Plasminogen Activator Therapy Protocol: A Joint Pediatric Hematology and Cardiac ICU Quality Improvement Initiative Analysis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric thromboembolism is increasingly encountered in critical care. Systemic thrombolysis with tissue plasminogen activator (tPA) facilitates vessel or valve patency, yet pediatric‐specific protocols remain undefined, and safety concerns persist. Objective To evaluate the efficacy and safety of a tailored, prolonged systemic tPA
Eran Shostak, Oded Gilad, Yael Feinstein, Sigal Nakav, Ofer Schiller, Joanne Yacobovich   +5 more
wiley   +1 more source